The Evolving Role of the Startup CFO in 2024: Beyond Financial Management
In 2024, the role of the startup CFO extends far beyond traditional financial management. Today’s CFOs are pivotal in strategic…
This blog summarises the accounting and tax rules applicable for companies engaged in R&D activities in Switzerland. Understanding these rules can significantly enhance your company’s profitability and tax efficiency.
One effective strategy to improve profitability is by using accrual accounting to allocate development costs to future periods that benefit from your current R&D efforts. This involves distinguishing between the research stage and the development stage of your R&D activities:
By capitalising development stage expenses, companies can reduce the immediate impact of R&D costs on profitability and spread these expenses over future periods that benefit from the R&D activities.
Swiss tax law provides significant incentives for R&D activities, primarily at the canton level. These incentives are designed to promote innovation and economic growth. The provisions should be structured such that at least 30% of the taxable profit is taxed, depending on the canton.
R&D super deductions are available in addition to the normal tax deduction, allowing for a maximum of 50% of the below-qualified expenses:
The patent box regime allows companies to claim relief for a maximum of 90% of the income earned from patents, significantly lowering their tax base. This regime applies to:
A tech company in Zurich is developing a new software product. The research stage costs amount to CHF 200,000 and are expensed as incurred. The development stage costs, totaling CHF 500,000, are capitalised. Over the next five years, these costs are amortised, reducing the annual impact on profitability.
A biotech firm in Geneva spends CHF 300,000 on qualified personnel for R&D and outsources additional R&D worth CHF 100,000. The company can deduct:
Total deduction: CHF 485,000
A pharmaceutical company earns CHF 1,000,000 from a patented drug. Under the patent box regime, it can claim relief for up to 90% of this income. Thus, only CHF 100,000 is subject to taxation, significantly lowering the company’s tax liability.
Leveraging accrual accounting and taking advantage of Swiss tax incentives can substantially enhance the financial performance of companies engaged in R&D. By capitalising development costs and utilising super deductions and patent box reliefs, businesses can reduce their taxable income, improve profitability, and reinvest savings into further innovation.